Logo image of TACT

TRANSACT TECHNOLOGIES INC (TACT) Stock Fundamental Analysis

NASDAQ:TACT - Nasdaq - US8929181035 - Common Stock - Currency: USD

3.72  -0.12 (-3.12%)

Fundamental Rating

3

TACT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 32 industry peers in the Technology Hardware, Storage & Peripherals industry. While TACT has a great health rating, there are worries on its profitability. TACT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year TACT has reported negative net income.
TACT had a positive operating cash flow in the past year.
TACT had negative earnings in 4 of the past 5 years.
In multiple years TACT reported negative operating cash flow during the last 5 years.
TACT Yearly Net Income VS EBIT VS OCF VS FCFTACT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

With a Return On Assets value of -22.40%, TACT is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
With a Return On Equity value of -32.20%, TACT perfoms like the industry average, outperforming 53.13% of the companies in the same industry.
Industry RankSector Rank
ROA -22.4%
ROE -32.2%
ROIC N/A
ROA(3y)-8.37%
ROA(5y)-9.27%
ROE(3y)-12.56%
ROE(5y)-13.34%
ROIC(3y)N/A
ROIC(5y)N/A
TACT Yearly ROA, ROE, ROICTACT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

With an excellent Gross Margin value of 49.52%, TACT belongs to the best of the industry, outperforming 84.38% of the companies in the same industry.
In the last couple of years the Gross Margin of TACT has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for TACT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.24%
GM growth 5Y0.64%
TACT Yearly Profit, Operating, Gross MarginsTACT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

7

2. Health

2.1 Basic Checks

TACT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TACT has more shares outstanding
The number of shares outstanding for TACT has been increased compared to 5 years ago.
TACT has a worse debt/assets ratio than last year.
TACT Yearly Shares OutstandingTACT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
TACT Yearly Total Debt VS Total AssetsTACT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

TACT has an Altman-Z score of 3.23. This indicates that TACT is financially healthy and has little risk of bankruptcy at the moment.
TACT has a better Altman-Z score (3.23) than 81.25% of its industry peers.
TACT has a debt to FCF ratio of 1.95. This is a very positive value and a sign of high solvency as it would only need 1.95 years to pay back of all of its debts.
TACT's Debt to FCF ratio of 1.95 is amongst the best of the industry. TACT outperforms 84.38% of its industry peers.
TACT has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
TACT's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. TACT outperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.95
Altman-Z 3.23
ROIC/WACCN/A
WACC9.16%
TACT Yearly LT Debt VS Equity VS FCFTACT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

TACT has a Current Ratio of 2.98. This indicates that TACT is financially healthy and has no problem in meeting its short term obligations.
TACT has a Current ratio of 2.98. This is amongst the best in the industry. TACT outperforms 84.38% of its industry peers.
A Quick Ratio of 1.72 indicates that TACT should not have too much problems paying its short term obligations.
TACT's Quick ratio of 1.72 is fine compared to the rest of the industry. TACT outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.98
Quick Ratio 1.72
TACT Yearly Current Assets VS Current LiabilitesTACT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for TACT have decreased strongly by -350.00% in the last year.
The Revenue for TACT has decreased by -40.27% in the past year. This is quite bad
TACT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.06% yearly.
EPS 1Y (TTM)-350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-40.27%
Revenue growth 3Y3.27%
Revenue growth 5Y-1.06%
Sales Q2Q%22.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.21%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TACT Yearly Revenue VS EstimatesTACT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
TACT Yearly EPS VS EstimatesTACT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TACT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TACT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TACT Price Earnings VS Forward Price EarningsTACT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of TACT indicates a somewhat cheap valuation: TACT is cheaper than 62.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.36
EV/EBITDA N/A
TACT Per share dataTACT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TACT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRANSACT TECHNOLOGIES INC

NASDAQ:TACT (5/22/2025, 8:00:00 PM)

3.72

-0.12 (-3.12%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners64.05%
Inst Owner Change-0.43%
Ins Owners4.12%
Ins Owner Change3.03%
Market Cap37.50M
Analysts82.5
Price Target6.89 (85.22%)
Short Float %0.08%
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)32.28%
Min EPS beat(2)26.47%
Max EPS beat(2)38.08%
EPS beat(4)4
Avg EPS beat(4)45.2%
Min EPS beat(4)26.47%
Max EPS beat(4)81.62%
EPS beat(8)8
Avg EPS beat(8)271.11%
EPS beat(12)11
Avg EPS beat(12)241.22%
EPS beat(16)14
Avg EPS beat(16)185.65%
Revenue beat(2)0
Avg Revenue beat(2)-7.57%
Min Revenue beat(2)-11.88%
Max Revenue beat(2)-3.25%
Revenue beat(4)1
Avg Revenue beat(4)-3.54%
Min Revenue beat(4)-11.88%
Max Revenue beat(4)8.95%
Revenue beat(8)4
Avg Revenue beat(8)1.92%
Revenue beat(12)7
Avg Revenue beat(12)4.2%
Revenue beat(16)11
Avg Revenue beat(16)4.94%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-66.67%
EPS NY rev (1m)12.28%
EPS NY rev (3m)-163.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.24%
Revenue NY rev (1m)1.88%
Revenue NY rev (3m)-3.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.86
P/FCF 24.36
P/OCF 20.15
P/B 1.22
P/tB 1.34
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)0.15
FCFY4.1%
OCF(TTM)0.18
OCFY4.96%
SpS4.3
BVpS3.04
TBVpS2.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.4%
ROE -32.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.52%
FCFM 3.55%
ROA(3y)-8.37%
ROA(5y)-9.27%
ROE(3y)-12.56%
ROE(5y)-13.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.24%
GM growth 5Y0.64%
F-Score3
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.95
Debt/EBITDA N/A
Cap/Depr 31.05%
Cap/Sales 0.74%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.98
Quick Ratio 1.72
Altman-Z 3.23
F-Score3
WACC9.16%
ROIC/WACCN/A
Cap/Depr(3y)63.1%
Cap/Depr(5y)77.66%
Cap/Sales(3y)1.41%
Cap/Sales(5y)2.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y-2%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.27%
Revenue growth 3Y3.27%
Revenue growth 5Y-1.06%
Sales Q2Q%22.14%
Revenue Next Year12.21%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-163.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year69.1%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-66.59%
FCF growth 3YN/A
FCF growth 5Y-15.06%
OCF growth 1Y-66.21%
OCF growth 3YN/A
OCF growth 5Y-17.43%